Difficulty: Medium
Average Score: 92%
Practice
Rheumatoid factor (RF)-positive polyarthritis usually accounts for
Correct answer
A
Rationale
In the case of a child with RF-positive polyarthritis, the least effective drug to induce remission would be NSAIDs (Option A). This is because NSAIDs primarily help with symptom management by reducing pain and inflammation but do not target the underlying disease process in JIA.
Methotrexate (Option B) is a disease-modifying antirheumatic drug (DMARD) commonly used in JIA to induce remission by suppressing the overactive immune response. TNF-a antagonists (Option C) and IL-6 inhibitors (Option D) are biologic agents that specifically target inflammatory pathways involved in JIA, making them more effective in inducing remission compared to NSAIDs.
Educationally, it is important for healthcare providers to understand the different treatment options for JIA and their mechanisms of action to provide optimal care for pediatric patients. By knowing which medications are more effective in managing the disease process, healthcare providers can tailor treatment plans to improve outcomes and quality of life for children with JIA.
Methotrexate (Option B) is a disease-modifying antirheumatic drug (DMARD) commonly used in JIA to induce remission by suppressing the overactive immune response. TNF-a antagonists (Option C) and IL-6 inhibitors (Option D) are biologic agents that specifically target inflammatory pathways involved in JIA, making them more effective in inducing remission compared to NSAIDs.
Educationally, it is important for healthcare providers to understand the different treatment options for JIA and their mechanisms of action to provide optimal care for pediatric patients. By knowing which medications are more effective in managing the disease process, healthcare providers can tailor treatment plans to improve outcomes and quality of life for children with JIA.